[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.169.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 1986

Fluid-Gas Exchange and Photocoagulation After VitrectomyIndications, Technique, and Results

Author Affiliations

From the Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine. Dr Blumenkranz is now with the Eye Research Institute, Oakland University, Rochester, Mich, and the Kresge Eye Institute, Wayne State University, Detroit. Dr Gardner was a Heed Fellow in retinal and vitreous diseases at the Bascom Palmer Eye Institute from 1983 to 1984; he is now with Franklin (Pa) Eye Associates.

Arch Ophthalmol. 1986;104(2):291-296. doi:10.1001/archopht.1986.01050140149039
Abstract

• We describe the indications, complications, and results of postvitrectomy fluid-gas exchange and laser photocoagulation for management of complicated vitreoretinal disease. Indications include proliferative vitreoretinopathy, vitreous opacities associated with proliferative diabetic retinopathy, giant retinal tear, recurrent rhegmatogenous retinal detachment, and trauma. Eyes treated with 50% sulfur hexafluoride gas rather than sterile air demonstrated a higher intraocular pressure on the first postexchange day, which was not a significant source of disease. There was no statistically significant difference in retinal reattachment between eyes treated with gas and those treated with air. Fluid-gas exchange in eyes with partial or total retinal detachment resulted in total or partial retinal reattachment, with the macula attached in 82% of cases within the first 48 hours following exchange. Final reattachment rate, with a mean follow-up of 8.9 months (range, six to 36 months), was 55%. In eyes with proliferative vitreoretinopathy, the combination of postoperative argon or krypton laser photocoagulation with fluid-gas exchange was associated with a final reattachment rate of 75%. Postoperative fluid-gas exchange and photocoagulation appear to be safe and effective advances in the treatment of complicated vitreoretinal diseases requiring vitrectomy.

References
1.
Norton EWD:  Postoperative management , in Schepens CL, Regan CDJ (eds): Controversial Aspects of the Management of Retinal Detachment . Boston, Little Brown & Co Inc, 1965, pp 321-326.
2.
Rachal WF, Burton TC:  Changing concepts of failure after retinal detachment surgery . Arch Ophthalmol 1979;97:480-483.Article
3.
Machemer R:  Massive periretinal proliferation: A logical approach to therapy . Ophthalmology 1977;75:556-585.
4.
Blumenkranz M, Hernandez E, Ophir A, et al:  5-Fluorouracil: New applications in complicated retinal detachment for an established antimetabolite . Ophthalmology 1984;91:122-130.Article
5.
Rosengren B:  The results of treatment of detachment of the retina with diathermy and injection of air into the vitreous . Acta Ophthalmol 1938;16:573-579.Article
6.
Norton EWD:  Intraocular gases in the management of selected retinal detachments . Ophthalmology 1973;77:85-98.
7.
Stern W, Blumenkranz MS:  Fluid-gas exchange after vitrectomy . Am J Ophthalmol 1983;96:400-402.
8.
Chang S, Coleman DJ, Lincoff H, et al:  Perfluoro-propane gas in the management of proliferative vitreoretinopathy . Am J Ophthalmol 1984;98:180-188.
9.
Abrams GW, Swanson DE, Sabates W, et al:  The results of sulfur hexafluoride gas in vitreous surgery . Am J Ophthalmol 1982;94:165-171.
10.
Blumenkranz M, Hajek A, Sossi N, et al:  Evidence for cell specificity in proliferative vitreoretinopathy . Invest Ophthalmol Vis Sci 1984;25( (suppl) ):272.
11.
Parke DW, Aaberg T:  Intraocular argon laser photocoagulation in the management of severe proliferative vitreoretinopathy . Am J Ophthalmol 1984;97:434-443.
12.
DeBustros S, Michels RA:  Surgical treatment of retinal detachments complicated by proliferative vitreoretinopathy . Am J Ophthalmol 1984;98:694-699.
13.
Jalkh AE, Avila MP, Schepens CL, et al:  Surgical treatments of proliferative vitreoretinopathy . Arch Ophthalmol 1984;102:1135-1139.Article
×